Literature DB >> 2131883

In vitro variability in fentanyl absorption by different membrane oxygenators.

D A Rosen1, K R Rosen, D L Silvasi.   

Abstract

The membrane oxygenator has replaced the bubble oxygenator in a wide variety of clinical settings. The membrane oxygenators now manufactured can be grouped into three categories based on composition and design: (1) silicone with a true membrane structure; (2) polypropylene with a microporous sheet; and (3) polypropylene with a microtubular structure. The capacity for fentanyl uptake by membrane oxygenators from these three categories was studied in vitro. Representative membrane samples were incubated in solutions containing tritiated fentanyl in Normosol-R (Abbott, North Chicago, IL) with pH adjusted to 7.4 at 37 degrees C. Fentanyl analysis was performed using liquid scintillation and radioimmunoassay techniques. The uptake of fentanyl at various concentrations (340 to 10 ng/mL) was studied. The SciMed (type 1; SciMed, Minneapolis, MN) membrane showed the greatest capacity for fentanyl uptake at all concentrations. The SciMed oxygenator was capable of binding 130 ng fentanyl/cm2 membrane. When presented with a smaller concentration (less than or equal to 20 ng/mL) of fentanyl, the membrane was able to extract all available fentanyl from solution. All of the microporous polypropylene oxygenators (types 2 and 3) absorbed significantly less fentanyl than did the SciMed brand. When exposed to 10 or 20 ng/mL, the Shiley and Omnis brands (type 2) absorbed 0.1 and 0.4 ng/cm2, respectively. Using the higher fentanyl concentrations (greater than or equal to 200 ng/mL) uptake by the Omnis membrane was 11 ng/cm2 compared with only 2 ng/cm2 by the Shiley. The Bentley BCM 7 and Terumo Capiox II 08 microtubular microporous membranes (type 3) did not show absorption of fentanyl using isolated or intact membrane models.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2131883     DOI: 10.1016/0888-6296(90)90041-d

Source DB:  PubMed          Journal:  J Cardiothorac Anesth        ISSN: 0888-6296


  15 in total

1.  Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment.

Authors:  Nilesh M Mehta; David R Halwick; Brenda L Dodson; John E Thompson; John H Arnold
Journal:  Intensive Care Med       Date:  2007-04-03       Impact factor: 17.440

Review 2.  Considerations for analgosedation and antithrombotic management during extracorporeal life support.

Authors:  Pamela K Burcham; Alan J Rozycki; Erik E Abel
Journal:  Ann Transl Med       Date:  2017-02

Review 3.  Clinical Pharmacology Studies in Critically Ill Children.

Authors:  Nilay Thakkar; Sara Salerno; Christoph P Hornik; Daniel Gonzalez
Journal:  Pharm Res       Date:  2016-09-01       Impact factor: 4.200

Review 4.  Pediatric cardiovascular drug dosing in critically ill children and extracorporeal membrane oxygenation.

Authors:  Kevin Watt; Jennifer S Li; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal:  J Cardiovasc Pharmacol       Date:  2011-08       Impact factor: 3.105

5.  The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.

Authors:  Enno D Wildschut; Annewil van Saet; Pavla Pokorna; Maurice J Ahsman; John N Van den Anker; Dick Tibboel
Journal:  Pediatr Clin North Am       Date:  2012-08-29       Impact factor: 3.278

6.  Medication adsorption into contemporary extracorporeal membrane oxygenator circuits.

Authors:  Aaron A Harthan; Klayton W Buckley; Margaret L Heger; Randall S Fortuna; Kyle Mays
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

7.  Determinants of drug absorption in different ECMO circuits.

Authors:  E D Wildschut; M J Ahsman; K Allegaert; R A A Mathot; D Tibboel
Journal:  Intensive Care Med       Date:  2010-09-23       Impact factor: 17.440

8.  Propofol sequestration within the extracorporeal circuit.

Authors:  M Hynynen; E Hammarén; P H Rosenberg
Journal:  Can J Anaesth       Date:  1994-07       Impact factor: 5.063

9.  A Population Pharmacokinetic Analysis to Study the Effect of Extracorporeal Membrane Oxygenation on Cefepime Disposition in Children.

Authors:  Athena F Zuppa; Nicole R Zane; Ganesh Moorthy; Heidi J Dalton; Alan Abraham; Ron W Reeder; Joseph A Carcillo; Andrew R Yates; Kathleen L Meert; Robert A Berg; Anil Sapru; Peter Mourani; Daniel A Notterman; J Michael Dean; Marc R Gastonguay
Journal:  Pediatr Crit Care Med       Date:  2019-01       Impact factor: 3.624

10.  The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation.

Authors:  Kiran Shekar; Jason A Roberts; Maree T Smith; Yoke L Fung; John F Fraser
Journal:  BMC Anesthesiol       Date:  2013-03-21       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.